Huron Consulting Group Inc (HURN) Stock Analysis

Verdict: BUY

Record earnings beats and a major 2026 guidance raise propel HURN, but aggressive insider selling and a high debt load cap the upside.

Investment score: 74/100

Analysis as of

Is Huron Consulting Group Inc stock worth reviewing? The TradeMates thesis

Huron is demonstrating strong operational leverage in its Healthcare and Education segments, evidenced by a 4-quarter streak of earnings beats and a significant guidance upgrade for 2026. Despite a 50% weekly move, the forward valuation remains reasonable compared to high-growth peers like EXPO and INOD.

7-factor investment score

Huron Consulting Group Inc opportunities and risks

What speaks for HURN

What speaks against HURN

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
HURN24.0x1.4x14.7x30.5%6.4%6.2%
KBR10.4x0.6x11.3x14.5%5.5%8.0%
AMTM36.2x0.4x9.2x7.9%1.0%8.5%
EXPO39.4x10.6x26.5x24.6%27.9%3.6%
CBZ26.6x1.1x7.4x12.2%4.4%9.6%
INOD48.8x6.9x32.5x40.9%13.9%3.2%
Peer median36.2x1.1x11.3x14.5%5.5%8.0%

Frequently asked questions about Huron Consulting Group Inc (HURN)

Is HURN stock a good investment?

The TradeMates model rates Huron Consulting Group Inc as BUY with an investment score of 74/100. Huron is demonstrating strong operational leverage in its Healthcare and Education segments, evidenced by a 4-quarter streak of earnings beats and a significant guidance upgrade for 2026. Despite a 50% weekly move, the forward valuation remains reasonable compared to high-growth peers like EXPO and INOD. This is algorithmic model output, not personal investment advice.

Is HURN stock a buy?

The TradeMates model verdict for HURN is BUY with an investment score of 74/100. Treat this as a model signal to review, not a personal buy recommendation.